Increased TRAF3 bound to TAK1 and promoted TAK1 autophosphorylation and activation, resulting in activated downstream MAPKs pathway and cardiomyocyte apoptosis in doxorubicin-induced cardiomyopathy (Schematic diagram). The gene discussed is TRAF3; the disease is cardiomyopathy.